Aspirin Monotherapy Versus Sequential Warfarin-Aspirin Therapy After TAVR in Patients With Pure Aortic Regurgitation

NCT07677410 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

1172

Enrollment

OTHER

Sponsor class

Conditions

Aortic Regurgitation Disease

Interventions

DRUG: Aspirin
DRUG: Warfarin

Sponsor

Shanghai Zhongshan Hospital

Collaborators

[object Object]